Item 8.01 Other events.
On September 29, 2021, ViewRay, Inc. ("ViewRay" or the "Company") issued a press
release announcing that it received acceptance from the U.S. Food and Drug
Administration, ("FDA") on the recent submission for new MRIdian features
focused on enhancing on-table adaptive workflow efficiency and expanding
clinical utility.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number               Description
                  99.1         Press Release dated     September 29    ,

2021 announcing 501(k) pending


                             status of the new    est generation of MRIdian

Innovations .


                   104       Cover Page Interactive Data File (embedded

within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses